State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Accéder directement au contenu
Article Dans Une Revue Frontiers in Medicine Année : 2015

State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET

Clément Bailly
  • Fonction : Auteur
  • PersonId : 1005354

Résumé

(18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from (18)F-FDG-PET allowed the development of a wide range of PET quantitative analysis techniques ranging from simple semi-quantitative methods like the standardized uptake value (SUV) to "high order metrics" that require a segmentation step and additional image processing. In this review, these methods are discussed, focusing particularly on the available methodologies that can be used in clinical trials as well as their current applications in international consensus for PET interpretation in lymphoma and solid tumors.

Domaines

Cancer

Dates et versions

inserm-01817854 , version 1 (18-06-2018)

Identifiants

Citer

Thomas Carlier, Clément Bailly. State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET. Frontiers in Medicine, 2015, 2, ⟨10.3389/fmed.2015.00018⟩. ⟨inserm-01817854⟩
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More